| Aktie | Ticker | Breite | GCS | 2025/Q4 | 2025/Q3 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 1.135.479.224 $ | +810.402.249 $ | +16,6 % | 15 | 732.378.332 $ | +663.954.631 $ | +17,6 % | 10 | ||||
| NORFOLK SOUTHERN CORP | NSC | → 0 | Neutral | 141.765.851 $ | +42.942.076 $ | +43,5 % | 1 | 98.823.775 $ | +98.823.775 $ | 1 | |
| Confluent, Inc. | CFLT | → 0 | 113.400.000 $ | +113.400.000 $ | 1 | ||||||
| Verona Pharma plc | VRNA | → 0 | 102.691.408 $ | +102.691.408 $ | 1 | ||||||
| EXACT SCIENCES CORP | EXAS | → 0 | 102.505.727 $ | +102.505.727 $ | 1 | ||||||
| Merus N.V. | → 0 | 99.187.025 $ | +99.187.025 $ | 1 | |||||||
| CyberArk Software Ltd. | → 0 | 90.696.042 $ | -6.827.786 $ | -7,0 % | 1 | 97.523.828 $ | +97.523.828 $ | 1 | |||
| Maverick Merger Sub 2, LLC | COOP | → 0 | 85.764.760 $ | +85.764.760 $ | 1 | ||||||
| Frontier Communications Parent, Inc. | → 0 | 83.286.082 $ | +2.798.064 $ | +3,5 % | 1 | 80.488.018 $ | +12.064.317 $ | +17,6 % | 1 | ||
| Dayforce, Inc. | DAY | → 0 | 77.840.410 $ | +77.840.410 $ | 1 | ||||||
| Avidity Biosciences, Inc. | RNA | → 0 | 75.398.932 $ | +75.398.932 $ | 1 | ||||||
| DigitalBridge Group, Inc. | DBRG | → 0 | Neutral | 75.234.248 $ | +75.234.248 $ | 1 | |||||
| ELECTRONIC ARTS INC. | EA | → 0 | Neutral | 61.868.468 $ | +61.868.468 $ | 1 | |||||
| CHART INDUSTRIES INC | GTLS | → 0 | 60.916.217 $ | +12.674.863 $ | +26,3 % | 1 | 48.241.354 $ | +48.241.354 $ | 1 | ||
| Clearwater Analytics Holdings, Inc. | CWAN | → 0 | 59.537.808 $ | +59.537.808 $ | 1 | ||||||
| SUMISHO AIR LEASE CORP | AL | → 0 | 55.276.210 $ | +55.276.210 $ | 1 | ||||||
| HOLOGIC INC | HOLX | → 0 | 54.179.184 $ | +54.179.184 $ | 1 | ||||||
| MAC Copper Ltd | → 0 | 44.694.534 $ | +44.694.534 $ | 1 | |||||||
| AMICUS THERAPEUTICS, INC. | FOLD | → 0 | 42.640.256 $ | +42.640.256 $ | 1 | ||||||
| Cidara Therapeutics, Inc. | → 0 | 40.933.789 $ | +40.933.789 $ | 1 | |||||||
| Informatica Inc. | INFA | → 0 | 40.418.630 $ | +40.418.630 $ | 1 | ||||||
| 89bio, Inc. | → 0 | 34.545.000 $ | +34.545.000 $ | 1 | |||||||
| 1.135.479.224 $ | +810.402.249 $ | +16,6 % | 15 | 732.378.332 $ | +663.954.631 $ | +17,6 % | 10 | ||||